A genetic inheritance from Neanderthals holds therapeutic promise for a 21st century pandemic
Montreal, July 8, 2021 – Earlier this year, a team of researchers with the Lady Davis Institute (LDI) at the Jewish General Hospital (JGH) and the Biobanque Quebec COVID-19 discovered that people who had elevated levels of the protein OAS1 experienced less severe illness and lower rates of mortality when infected with COVID-19. In a […]
PrecisionLife and Cyclica Sign Strategic Partnership Combining Leading Data-driven Biology and Chemistry Platforms to Create a Rapid Innovation Engine for Drug Discovery
OXFORD, England & TORONTO, May 17, 2021 — PrecisionLife Ltd. (“PrecisionLife”), the leading combinatorial analytics company driving understanding of disease biology and patient stratification, and Cyclica Inc. (“Cyclica”), the partner of choice for data-driven drug discovery, announce that they have entered into a strategic partnership to co-market and offer their complementary computational platforms as an […]
Cyclica teams with academics to investigate COVID-19 treatment
This post was adapted from its original source on Outsourcing Pharma and can be viewed here. The drug-discovery firm has partnered with several academic institutions to explore a Novartis lung-cancer treatment’s potential in treating COVID-19. Read the full article on Outsourcing Pharma →
Cyclica Teams Up with Top-Tier Academic Institutions to Identify a Repurposed Drug for COVID
New findings accelerated by Cyclica’s drug discovery platform suggests that lung cancer drug, capmatinib, demonstrates robust antiviral effects in experimental COVID-19 models TORONTO, April 14, 2021 – Cyclica, the partner of choice for data driven drug discovery, in connection with leading Canadian research institutions, has predicted a drug, capmatinib, can be repurposed to attenuate the […]
Cyclica Appoints Renowned Healthcare AI Executive, Sastry Chilukuri, to Board of Directors to Help Build the Biotech Pipeline of the Future
This post was adapted from its original source on Business Wire and can be viewed here. NEW YORK & TORONTO – (January 7, 2021) – Cyclica announced the election of Sastry Chilukuri to its Board of Directors effective immediately. Chilukuri was also appointed to the Compensation and Governance sub-committees. Chilukuri, a health technology thought leader, is currently […]
Cyclica to use Excelra’s GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification
This post was adapted from its original source on PRNewswire and can be viewed here. HYDERABAD & TORONTO – (October 21, 2020) – Excelra, a leading global Data & Analytics organization, today announced that it has licensed its Global Online Structure Activity Relationship Database (GOSTAR) to Cyclica Inc., a leading biotechnology company whose AI-augmented integrated platform enables […]
Cyclica Receives a $2.0M Grant from FedDev Ontario to Advance Health Innovation
This post was adapted from its original source and can be viewed here. TORONTO – (October 9, 2020) – The COVID-19 pandemic has highlighted the critical importance of keeping Canada at the cutting edge of health technology to offer the best possible care to Canadians, while supporting economic growth. The Government of Canada is partnering with […]
Cerevel Therapeutics and Cyclica Announce Research Collaboration to Use Artificial Intelligence to Accelerate Discovery of Novel Medicines in Neuroscience
This post was adapted from its original source on Business Wire and can be viewed here. BOSTON & TORONTO – (July 27, 2020) – Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, and Cyclica, whose AI-augmented, integrated platform enables multi-objective, polypharmacology-informed design of drug molecules, today announced a research collaboration […]
FMC Corporation Collaborates with Cyclica to Improve Research Efficiency Using Artificial Intelligence
This post was adapted from its original source on PRNewswire and can be viewed here. PHILADELPHIA – (June 29, 2020) – FMC Corporation (NYSE: FMC) has entered into a collaboration with Cyclica, Inc, a leading biotechnology company specializing in artificial intelligence (AI) and computational biophysics, to accelerate and improve the efficiency of discovering new crop protection chemistry. This […]
Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future
This post was adapted from its original source on Business Wire and can be viewed here. Led by Drive Capital, the investment round includes Chiesi Farmaceutici, GreenSky Capital, and members of management. Proceeds will advance Cyclica’s AI-augmented, polypharmacology-enabled, drug discovery platforms, Ligand Design and Ligand Express, and accelerate commercial plans to advance a growing pipeline […]